Dyne Therapeutics (DYN)
NASDAQ:DYN
Want to see DYN full AI Analyst Report?
Dyne Therapeutics (DYN) Ownership Overview
3.92% Insiders
24.18% Mutual Funds
0.67% Other Institutional Investors
13.88% ETFs
57.34% Public Companies and
Individual Investors
The ownership structure of Dyne Therapeutics (DYN) stock is a mix of institutional, retail, and individual investors. Approximately 38.74% of the company’s stock is owned by Institutional Investors, 3.92% is owned by Insiders, and 57.34% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 01, 2026 | xxxxxxxxxxxxx | $34160 | |
Mar 13, 2026 | xxxxxxxxxxxxx | $38700 | |
Mar 10, 2026 | xxxxxxxxxxxxx | $45180 | |
Jul 15, 2025 | xxxxxxxxxxxxx | $911000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $15911062 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $4891271 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $68048145 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $707427 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,213,402 | Institution | 6.18% | 177,611,061 | |
| 9,714,392 | Institution | 5.88% | 168,933,277 | |
| 8,868,704 | Institution | 5.37% | 154,226,763 | |
| 5,884,796 | Institution | 3.56% | 102,336,602 | |
| 5,438,301 | Institution | 3.29% | 94,572,054 | |
| 4,196,573 | Insider | 2.54% | 72,978,404 | |
| 4,087,683 | Institution | 2.47% | 71,084,807 | |
| 3,478,944 | Institution | 2.11% | 60,498,836 | |
| 2,949,919 | Institution | 1.79% | 51,299,091 | |
| 2,728,079 | Institution | 1.65% | 47,441,294 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,868,704 | Institution | 5.37% | 154,226,763 | |
| 5,438,301 | Institution | 3.29% | 94,572,054 | |
| 2,949,919 | Institution | 1.79% | 51,299,091 | |
| 2,728,079 | Institution | 1.65% | 47,441,294 | |
| 2,636,221 | Institution | 1.60% | 45,843,883 | |
| 2,466,223 | Institution | 1.49% | 42,887,618 | |
| 1,447,862 | Institution | 0.88% | 25,178,320 | |
| 1,368,144 | Institution | 0.83% | 23,792,024 | |
| 1,343,691 | Institution | 0.81% | 23,366,786 | |
| 1,162,247 | Institution | 0.70% | 20,211,475 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,647,556 | Institution | 2.81% | 84,260,190 | |
| 3,832,337 | Institution | 2.32% | 67,257,514 | |
| 3,125,734 | Institution | 1.89% | 54,356,514 | |
| 1,707,174 | Institution | 1.03% | 30,951,065 | |
| 1,604,082 | Institution | 0.97% | 29,082,007 | |
| 1,087,468 | Institution | 0.66% | 19,715,795 | |
| 911,994 | Institution | 0.55% | 15,859,576 | |
| 768,693 | Institution | 0.47% | 13,367,571 | |
| 701,703 | Institution | 0.42% | 12,314,888 | |
| 656,084 | Institution | 0.40% | 11,894,803 |
FAQ
Who Owns Dyne Therapeutics (DYN)?
According to the latest TipRanks data, approximately 0.67% of the company's stock is held by institutional investors, 3.92% is held by insiders, and 57.34% is held by retail investors.
What percentage of Dyne Therapeutics (DYN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.67% of Dyne Therapeutics (DYN) stock is held by institutional investors.
What percentage of Dyne Therapeutics (DYN) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.34% of Dyne Therapeutics (DYN) stock is held by retail investors.
Who owns the most shares of Dyne Therapeutics (DYN)?
Vanguard owns the most shares of Dyne Therapeutics (DYN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.